Cancer Vaccine Market Anticipates Robust Growth with a Projected 8.87% CAGR Through 2028
22 janv. 2024 23h48 HE
|
Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Cancer Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ResearchAndMarkets.com's...
Cancer Vaccines Market Size, Share & Growth Analysis, [2029] | With CAGR of 14.7%
19 déc. 2023 05h08 HE
|
Fortune Business Insights
Pune, India, Dec. 19, 2023 (GLOBE NEWSWIRE) -- The size of the global cancer vaccines market is anticipated to increase at a CAGR of 14.7% throughout the forecast period, from USD 7.32 billion in...
Global Neoantigen Cancer Vaccine Research Report 2023: An $8.872 Billion Market by 2031 - Growing at a Staggering CAGR of 69.4%
27 sept. 2023 04h28 HE
|
Research and Markets
Dublin, Sept. 27, 2023 (GLOBE NEWSWIRE) -- The "Global Neoantigen Cancer Vaccine Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering. The global...
Innovative Therapeutic Cancer Vaccines Drive Unprecedented Growth in Global Cancer Vaccines Market to 2028
26 sept. 2023 08h43 HE
|
Research and Markets
Dublin, Sept. 26, 2023 (GLOBE NEWSWIRE) -- The "Cancer Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
Cancer Vaccine Market Size to Surpass Around USD 26.89 Billion by 2032
18 sept. 2023 14h09 HE
|
Precedence Research
Ottawa, Sept. 18, 2023 (GLOBE NEWSWIRE) -- According to Precedence Research, the global cancer vaccine market size was valued at USD 9.12 billion in 2022. A vaccine developed for vaccine is type of...
Global Human Papillomavirus Vaccine Market Research Report 2023-2028: Breakdown of Current and Upcoming Clinical Trials with Opportunities for Growth
07 sept. 2023 08h33 HE
|
Research and Markets
Dublin, Sept. 07, 2023 (GLOBE NEWSWIRE) -- The "Human Papillomavirus Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Valence, By Disease...
Key Insights: Over 40 Clinical Trials for mRNA Cancer Vaccines, Phase 3 Trials Prominent; No Commercial Approvals as of August 2023
05 sept. 2023 09h18 HE
|
Research and Markets
Dublin, Sept. 05, 2023 (GLOBE NEWSWIRE) -- The "Global mRNA Cancer Vaccines Market Opportunity & Clinical Pipeline Insight 2023" drug pipelines has been added to ResearchAndMarkets.com's...
Cancer Vaccines market is projected to grow at a CAGR of 14% by 2033: Visiongain
25 août 2023 11h32 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Cancer Vaccines Market Report 2023-2033: Forecasts by Type (Preventive Vaccines, Therapeutic Vaccines), by Technology (Dendritic Cells, Recombinant,...
Cancer Vaccines Market Size to Surpass USD 19.12 Billion by 2029, exhibiting a CAGR of 14.7%
25 août 2023 02h21 HE
|
Fortune Business Insights
Pune, India, Aug. 25, 2023 (GLOBE NEWSWIRE) -- The global cancer vaccines market size was valued at USD 6.43 billion in 2021 and is expected to grow from USD 7.32 billion in 2022 to USD 19.12...
Global Cancer Vaccine Market Research Report 2023: Synergistic Strategies - Combining Cancer Vaccines with Targeted Therapies for Enhanced Treatment Outcomes
17 juil. 2023 06h38 HE
|
Research and Markets
Dublin, July 17, 2023 (GLOBE NEWSWIRE) -- The "Global Cancer Vaccine Market ,Vaccine Price, Dosage, Sales & Clinical Trials Outlook 2029" report has been added to ResearchAndMarkets.com's...